Bridgewater Advisors Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1600319 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$212,003

-$34,469 QoQ

Shares Held

340

+6.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,036

of 1,322 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Advisors Inc. holds $1,270,177 across 4 Biotechnology names. REGN ranks #3 (16.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,103	$547,893
2	ARGX	Argenx SE	335	$310,802
3	REGN	Regeneron Pharmaceuticals, Inc. This page	340	$212,003
4	TTRX	Turn Therapeutics Inc.	27,326	$199,479

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,003	340	+6.6%	Shares	Sole	2026-08-05
2026-03-31	$246,472	319	-0.9%	Shares	Sole	2026-05-14
2025-12-31	$248,542	322	—	Shares	Sole	2026-01-23
No filing history on record for this holder in this stock.